Oropharyngeal colonization by Streptococcus pneumoniae among HIV-infected adults in Uganda: assessing prevalence and antimicrobial susceptibility

International Journal of Infectious Diseases

Volumn 10, Issue 6, 2006, Pages 458-464

  Blossom, David B ^a,b   Namayanja Kaye, Grace ^c   Nankya Mutyoba, Joan ^c   Mukasa, John B ^c   Bakka, Henry ^c   Rwambuya, Sandra ^c   Windau, Anne ^a   Bajaksouzian, Saralee ^a   Walker, Courtney J ^a   Joloba, Moses L ^d   Kityo, Cissy ^c   Mugyenyi, Peter ^c   Whalen, Christopher C ^a   Jacobs, Michael R ^a,b   Salata, Robert A ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^c JOINT CLINICAL RESEARCH CENTRE   (Uganda)

^d MAKERERE UNIVERSITY   (Uganda)

Author keywords

Antibiotic resistance; HIV; Oropharyngeal colonization; Pneumococcus; Streptococcus pneumoniae; Uganda

Indexed keywords

COTRIMOXAZOLE;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; EVALUATION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; OROPHARYNX; POPULATION RESEARCH; PREVALENCE; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; UGANDA;

ADULT; AMBULATORY CARE FACILITIES; ANTI-INFECTIVE AGENTS; CARRIER STATE; CROSS-SECTIONAL STUDIES; DRUG RESISTANCE, BACTERIAL; FEMALE; HIV; HIV INFECTIONS; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; OROPHARYNX; PNEUMOCOCCAL INFECTIONS; PREVALENCE; QUESTIONNAIRES; SEROTYPING; SPECIES SPECIFICITY; STREPTOCOCCUS PNEUMONIAE; SULFAMETHOXAZOLE; TRIMETHOPRIM; UGANDA;

EID: 33750376097     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijid.2006.05.010     Document Type: Article

References (24)

1. Jacobs M.R. Streptococcus pneumoniae: epidemiology and patterns of resistance. Am J Med 117 (2004) S3-S15
2. Whitney C.G., Farley M.M., Hadler J., Harrison L.H., Lexau C., Reingold A., et al. Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. N Engl J Med 343 (2000) 1917-1924
3. Kramer M.R., Rudensky B., Hadas-Halperin I., Isacsohn M., and Melzer E. Pneumococcal bacteremia-no change in mortality in 30 years: analysis of 104 cases and review of the literature. Isr J Med Sci 23 (1987) 174-180
4. Rodriguez-Barradas M.C., Tharapel R.A., Groover J.E., Giron K.P., Lacke C.E., Houston E.D., et al. Colonization by Streptococcus pneumoniae among human immunodeficiency virus-infected adults: prevalence of antibiotic resistance, impact of immunization, and characterization by polymerase chain reaction with BOX primers of isolates from persistent S. pneumoniae carriers. J Infect Dis 175 (1997) 590-597
5. Joloba M.L., Bajaksouzian S., Palavecino E., Whalen C., and Jacobs M.R. High prevalence of carriage of antibiotic-resistant Streptococcus pneumoniae in children in Kampala Uganda. Int J Antimicrob Agents 17 (2001) 395-400
6. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; fifteenth informational supplement. CLSI document M100-S15. Wayne, PA, USA: Clinical and Laboratory Standards Institute; 2005.
7. Felmingham D., White A.R., Jacobs M.R., Appelbaum P.C., Poupard J., Miller L.A., et al. The Alexander Project: the benefits from a decade of surveillance. J Antimicrob Chemother 56 (2005) ii3-ii21
8. Farrell D.J., Jenkins S.G., Brown S.D., Patel M., Lavin B.S., and Klugman K.P. Emergence and spread of Streptococcus pneumoniae with erm(B) and mef(A) resistance. Emerg Infect Dis 11 (2005) 851-858
9. Pottumarthy S., Fritsche T.R., Sader H.S., Stilwell M.G., and Jones R.N. Susceptibility patterns of Streptococcus pneumoniae isolates in North America (2002-2003): contemporary in vitro activities of amoxicillin/clavulanate and 15 other antimicrobial agents. Int J Antimicrob Agents 25 (2005) 282-289
10. Gwanzura L., Pasi C., Nathoo K.J., Hakim J., Gangaidzo I., Mielke J., et al. Rapid emergence of resistance to penicillin and trimethoprim-sulphamethoxazole in invasive Streptococcus pneumoniae in Zimbabwe. Int J Antimicrob Agents 21 (2003) 557-561
11. Adrian P.V., and Klugman K.P. Mutations in the dihydrofolate reductase gene of trimethoprim-resistant isolates of Streptococcus pneumoniae. Antimicrob Agents Chemother 41 (1997) 2406-2413
12. Jones M.E., Blosser-Middleton R.S., Thornsberry C., Karlowsky J.A., and Sahm D.F. The activity of levofloxacin and other antimicrobials against clinical isolates of Streptococcus pneumoniae collected worldwide during 1999-2002. Diagn Microbiol Infect Dis 47 (2003) 579-586
13. Beekmann S.E., Heilmann K.P., Richter S.S., Garcia-de-Lomas J., Doern G.V., and the GRASP Study Group. Antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis and group A beta-haemolytic streptococci in 2002-2003. Results of the multinational GRASP Surveillance Program. Int J Antimicrob Agents 25 (2005) 148-156
14. Mera R.M., Miller L.A., Daniels J.J.D., Weil J.G., and White A.R. Increasing prevalence of multi-drug resistant Streptococcus pneumoniae in the United States over a 10-year period: Alexander project. Diagn Microbiol Infect Dis 51 (2005) 195-200
15. Huebner R.E., Wasas A.D., and Klugman K.P. Trends in antimicrobial resistance and serotype distribution of blood and cerebrospinal fluid isolates of Streptococcus pneumoniae in South Africa, 1991-1998. Int J Infect Dis 4 (2000) 214-218
16. Rusen I.D., Fraser-Roberts L., Slaney L., Ombette J., Lovgren M., Datta P., et al. Nasopharyngeal pneumococcal colonization among Kenyan children: antibiotic resistance, strain types and associations with human immunodeficiency virus type 1 infection. Pediatr Infect Dis J 16 (1997) 656-662
17. Fernandez G.M., Ramos J.M., Marrero J., Cuenca M., Fernandez R.R., and de Gorgolas M. Bacteremic pneumococcal infections in immunocompromised patients without AIDS: the impact of beta-lactam resistance on mortality. Int J Infect Dis 7 (2003) 46-52
18. Park D.R., Sherbin V.L., Goodman M.S., Pacifico A.D., Rubenfeld G.D., Polissar N.L., et al. The etiology of community-acquired pneumonia at an urban public hospital: influence of human immunodeficiency virus infection and initial severity of illness. J Infect Dis 184 (2001) 268-277
19. Paul J., Kimari J., and Gilks C. Streptococcus pneumoniae resistant to penicillin and tetracycline associated with HIV seropositivity. Lancet 346 (1995) 1034-1035
20. Ruhe J.J., and Hasbun R. Streptococcus pneumoniae bacteremia: duration of previous antibiotic use and association with penicillin resistance. Clin Infect Dis 36 (2003) 1132-1138
21. Widdowson C.A., and Klugman K.P. Molecular mechanisms of resistance to commonly used non-betalactam drugs in Streptococcus pneumoniae. Semin Respir Infect 14 (1999) 255-268
22. Watt J.P., O'Brien K.L., Katz S., Bronsdon M.A., Elliott J., Dallas J., et al. Nasopharyngeal versus oropharyngeal sampling for detection of pneumococcal carriage in adults. J Clin Microbiol 42 (2004) 4974-4976
23. MLST database. Available at: http://www.mlst.net (accessed 12 April 2006).
24. French N., Nakiyingi J., Carpenter L.M., Lugada E., Watera C., Moi K., et al. 23-valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults: double-blind, randomised and placebo controlled trial. Lancet 355 (2000) 2106-2111